Neurochemical biomarkers in Alzheimer’s disease and related disorders

Measurement of ERK 1/2 in CSF from Patients with Neuropsychiatric Disorders and Evidence for the Presence of the Activated Form

(2017) Hans-Wolfgang Klafki et al.   JOURNAL OF ALZHEIMERS DISEASE

ERK2 is Increased in Cerebrospinal Fluid of Creutzfeldt-Jakob Disease Patients

(2017) Petra Steinacker et al.   JOURNAL OF ALZHEIMERS DISEASE

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI

(2011) Leslie M. Shaw et al.   ACTA NEUROPATHOLOGICA

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Cerebrospinal Fluid Tau, p-Tau 181 and Amyloid-β38/40/42 in Frontotemporal Dementias and Primary Progressive Aphasias

(2010) Mirko Bibl et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

CSF amyloid  38 as a novel diagnostic marker for dementia with Lewy bodies

(2010) E. Mulugeta et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Plasma A 42 and A 40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study

(2010) T. T. Seppala et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels

(2009) Holly D. Soares et al.   Annals of the New York Academy of Sciences

Rapid Progression from Mild Cognitive Impairment to Alzheimer’s Disease in Subjects with Elevated Levels of Tau in Cerebrospinal Fluid and the APOE ε4/ε4 Genotype

(2009) Elin S. Blom et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid

(2009) Erik Portelius et al.   EXPERIMENTAL NEUROLOGY

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

(2009) P. Lewczuk et al.   EXPERIMENTAL NEUROLOGY

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration

(2009) Petra Steinacker et al.   JOURNAL OF NEURAL TRANSMISSION

Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease

(2009) Volker Welge et al.   JOURNAL OF NEURAL TRANSMISSION

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

(2009) Josef Marksteiner et al.   NEUROBIOLOGY OF AGING

Identification of Novel APP/Aβ Isoforms in Human Cerebrospinal Fluid

(2009) Erik Portelius et al.   Neurodegenerative Diseases

Association of plasma amyloid   with risk of dementia: The prospective Three-City Study

(2009) J. -C. Lambert et al.   NEUROLOGY

TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

(2008) Petra Steinacker et al.   ARCHIVES OF NEUROLOGY

Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease

(2008) Henrik Zetterberg et al.   ARCHIVES OF NEUROLOGY

Cerebrospinal Fluid Neurochemical Phenotypes in Vascular Dementias: Original Data and Mini-Review

(2008) Mirko Bibl et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

(2008) Brit Mollenhauer et al.   EXPERIMENTAL NEUROLOGY

Diagnostic and prognostic needs in neurodegenerative disorders: focus on proteomics

(2008) Mirko Bibl et al.   Expert Review of Proteomics

Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’- a new blood biomarker?

(2008) Kurt A. Jellinger et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

(2008) P Lewczuk et al.   MOLECULAR PSYCHIATRY

Prediction of Alzheimer’s Disease Using a Cerebrospinal Fluid Pattern of C-Terminally Truncated β-Amyloid Peptides

(2008) K. Höglund et al.   Neurodegenerative Diseases

CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

(2008) Mirko Bibl et al.   Proteomics Clinical Applications

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia

(2007) Sebastiaan Engelborghs et al.   NEUROBIOLOGY OF AGING

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study

(2007) Piotr Lewczuk et al.   NEUROBIOLOGY OF AGING